EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieStudienprotokollOpen Access

Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT)

Luca Bertolaccini iD, Oriana Ciani iD, Marco Lucchi iD, Francesco Zaraca iD, Alessandro Bertani iD, Roberto Crisci iD, Lorenzo Spaggiari iD, LUCENT Study Group

JMIR Research Protocols · 2024

DOI: 10.2196/57183 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JMIR Research Protocols, 2024. Verfasst von Luca Bertolaccini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung cancer, predominantly non-small cell lung cancer (NSCLC), remains a formidable challenge, necessitating an in-depth understanding of evolving treatment paradigms. The Italian Lung Cancer Observational Study (LUCENT) addresses this need by investigating the outcomes of patients with early and locally advanced lung cancer in Italy.

Objective

With a focus on real-world data and patient registries, this study aims to provide comprehensive insights into clinical, psychosocial, and economic impacts, contributing to informed decision-making in health care.

Methods

LUCENT is a prospective observational multicenter cohort study enrolling patients eligible for minimally invasive manual, robot-assisted, or traditional open surgery. The study will develop a web-based registry to collect longitudinal surgical, oncological, and socioeconomic outcome data. The primary objectives include performance assessment through the establishment of national benchmarks based on risk-adjusted outcomes and processes of care indicators. The secondary objectives encompass economic and psychosocial impact assessments of innovative technologies and treatment pathways. The multicenter design ensures a diverse and representative study population.

Results

The evolving landscape of NSCLC treatment necessitates a nuanced approach with consideration of the dynamic shifts in therapeutic strategies. LUCENT strives to fill existing knowledge gaps by providing a platform for collecting and analyzing real-world data, emphasizing the importance of patient-reported outcomes in enhancing the understanding of the disease. By developing a web-based registry, the study not only facilitates efficient data collection but also addresses the limitations of traditional methods, such as suboptimal response rates and costs associated with paper-and-pencil questionnaires. Recruitment will be conducted from January 01, 2024, to December 31, 2026. Follow-up will be performed for a minimum of 2 years. The study will be completed in the year 2028.

Conclusions

LUCENT’s potential implications are substantial. Establishing national benchmarks will enable a thorough evaluation of outcomes and care processes, guiding clinicians and policymakers in optimizing patient management. Furthermore, the study’s secondary objectives, focusing on economic and psychosocial impacts, align with the contemporary emphasis on holistic cancer care. Insights gained from this study may influence treatment strategies, resource utilization, and patient well-being, thereby contributing to the ongoing refinement of lung cancer management. Trial Registration ClinicalTrials.gov NCT05851755; https://clinicaltrials.gov/study/NCT05851755. ISRCTN 67197140; https://www.isrctn.com/ISRCTN67197140 International Registered Report Identifier (IRRID) PRR1-10.2196/57183

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsHumansItalyProspective StudiesCarcinoma, Non-Small-Cell LungFemaleMaleObservational Studies as TopicRegistriesTreatment OutcomeAgedMiddle AgedCohort Studies

Stichwörter der Autor:innen

economic aspectslung cancermulticenter studyobservational studyquality of life

Autor:innen und Institutionen

  • Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Centre for Research on Health and Social Care Management (CERGAS), Bocconi School of Management, Bocconi University, Milan, Italy.
  • Division of Thoracic Surgery, University of Pisa, Pisa, Italy.
  • Division of Thoracic Surgery, Regional Hospital, Bozen/Bolzano, Italy.
  • Unit of Thoracic Surgery and Lung Transplantation, Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializz…
  • Division of Thoracic Surgery, University of L'Aquila, L'Aquila, Italy.

ORCID-Profile: Luca Bertolaccini, Oriana Ciani, Marco Lucchi, Francesco Zaraca, Alessandro Bertani, Roberto Crisci, Lorenzo Spaggiari

Zitieren

APA

Bertolaccini, L., Ciani, O., Lucchi, M., Zaraca, F., Bertani, A., Crisci, R., Spaggiari, L., & LUCENT Study Group (2024). Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT). JMIR Research Protocols. https://doi.org/10.2196/57183

Vancouver

Bertolaccini L, Ciani O, Lucchi M, Zaraca F, Bertani A, Crisci R, et al. Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT). JMIR Research Protocols. 2024. doi:10.2196/57183

BibTeX
@article{Bertolaccini2024,
  author = {Bertolaccini, Luca and Ciani, Oriana and Lucchi, Marco and Zaraca, Francesco and Bertani, Alessandro and Crisci, Roberto and Spaggiari, Lorenzo and LUCENT Study Group, LUCENT Study Group},
  title = {Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT)},
  journal = {JMIR Research Protocols},
  year = {2024},
  doi = {10.2196/57183}
}
Kostenlos starten →